Pancreatic Cancer Research

ResearcherNational Center for Oncological HadrontherapyActive in the last 2 years

Francesca Valvo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5218-8274; OpenAlex author ID A5048482952. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper, 1 trial · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936). Co-author DOI 10.1177/03008916241291341↗
  2. Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? Co-author DOI 10.1016/j.pan.2020.05.007↗
  3. Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, mul… Last author DOI 10.1186/s12885-019-6108-0↗
  4. Morphological Analysis of Amoeboid-Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.12763↗

Trials 1

  1. Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma Principal investigator NCT03822936↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Viviana Vitolo · 3 shared papers, 2019–2024 · strength 0.36
  2. Amelia Barcellini · 3 shared papers, 2019–2024 · strength 0.36
  3. Angelica Facoetti · 3 shared papers, 2018–2024 · strength 0.34
  4. Ester M. Orlandi · 2 shared papers, 2020–2024 · strength 0.28
  5. Silvia Molinelli · 2 shared papers, 2019–2024 · strength 0.26
  6. Lorenzo Cobianchi · 2 shared papers, 2019–2020 · strength 0.18
  7. Giovanni Butturini · 1 shared paper, 2024 · strength 0.18
  8. Roberto Orecchia · 2 shared papers, 2018–2019 · strength 0.16
  9. Mario Ciocca · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.